JP2007502301A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007502301A5 JP2007502301A5 JP2006523413A JP2006523413A JP2007502301A5 JP 2007502301 A5 JP2007502301 A5 JP 2007502301A5 JP 2006523413 A JP2006523413 A JP 2006523413A JP 2006523413 A JP2006523413 A JP 2006523413A JP 2007502301 A5 JP2007502301 A5 JP 2007502301A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- platinum complex
- cells
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004027 cell Anatomy 0.000 claims 29
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims 22
- 238000000034 method Methods 0.000 claims 12
- 229910052697 platinum Inorganic materials 0.000 claims 11
- 210000004962 mammalian cell Anatomy 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 241000283690 Bos taurus Species 0.000 claims 2
- 241000282693 Cercopithecidae Species 0.000 claims 2
- 241000282326 Felis catus Species 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 241000282577 Pan troglodytes Species 0.000 claims 2
- 102000004495 STAT3 Transcription Factor Human genes 0.000 claims 2
- 108010017324 STAT3 Transcription Factor Proteins 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 210000005260 human cell Anatomy 0.000 claims 2
- 239000002502 liposome Substances 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 210000004881 tumor cell Anatomy 0.000 claims 2
- 102000007078 STAT Transcription Factors Human genes 0.000 claims 1
- 108010072819 STAT Transcription Factors Proteins 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 230000035755 proliferation Effects 0.000 claims 1
- 230000010076 replication Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48122603P | 2003-08-13 | 2003-08-13 | |
| US51558003P | 2003-10-30 | 2003-10-30 | |
| US51994303P | 2003-11-14 | 2003-11-14 | |
| US52529503P | 2003-11-25 | 2003-11-25 | |
| PCT/US2004/026392 WO2005023824A2 (en) | 2003-08-13 | 2004-08-13 | Methods for inhibiting tumor cell proliferation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007502301A JP2007502301A (ja) | 2007-02-08 |
| JP2007502301A5 true JP2007502301A5 (enExample) | 2007-09-27 |
Family
ID=34199238
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006523413A Pending JP2007502301A (ja) | 2003-08-13 | 2004-08-13 | 腫瘍細胞の増殖を阻害するための方法 |
| JP2006523414A Pending JP2007502777A (ja) | 2003-08-13 | 2004-08-13 | 腫瘍の処置のための白金錯体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006523414A Pending JP2007502777A (ja) | 2003-08-13 | 2004-08-13 | 腫瘍の処置のための白金錯体 |
Country Status (8)
| Country | Link |
|---|---|
| US (6) | US7566798B2 (enExample) |
| EP (2) | EP1675864B1 (enExample) |
| JP (2) | JP2007502301A (enExample) |
| AT (2) | ATE453653T1 (enExample) |
| AU (3) | AU2004264421B2 (enExample) |
| CA (2) | CA2535762A1 (enExample) |
| DE (2) | DE602004015811D1 (enExample) |
| WO (2) | WO2005016946A2 (enExample) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602004015811D1 (de) | 2003-08-13 | 2008-09-25 | Univ South Florida | Verfahren zur inhibierung der proliferation von tumorzellen, bei dem platinkomplexe eingesetzt werden |
| US20050288365A1 (en) | 2004-01-06 | 2005-12-29 | Heidi Kay | Platinum complexes and methods for inhibiting tumor cell proliferation |
| CA2563305A1 (en) * | 2004-04-09 | 2005-11-24 | University Of South Florida | Combination therapies for cancer and proliferative angiopathies |
| JP2008519859A (ja) | 2004-11-10 | 2008-06-12 | ユニバーシティー オブ サウス フロリダ | 標的化した薬物送達のための白金錯体 |
| US7951374B2 (en) | 2004-12-14 | 2011-05-31 | University Of South Florida | Methods for inhibiting STAT3 signaling in immune cells |
| DE102004060934A1 (de) * | 2004-12-17 | 2006-06-29 | Wacker Chemie Ag | Vernetzbare Polyorganosiloxanmassen |
| MX2007015852A (es) * | 2005-06-30 | 2008-02-22 | Bionumerik Pharmaceuticals Inc | Analogos de platino con ligandos de monoazol. |
| US20100190180A1 (en) * | 2005-07-06 | 2010-07-29 | Heidi Kay | Materials and Methods for Screening, Diagnosis and Prognosis of Conditions Associated With Stat Protein Expression |
| WO2007013946A2 (en) * | 2005-07-20 | 2007-02-01 | University Of South Florida | Method of predicting responsiveness to chemotherapy and selecting treatments |
| WO2007047623A2 (en) * | 2005-10-14 | 2007-04-26 | University Of South Florida | Methods of inhibiting cell growth and methods of enhancing radiation responses |
| DE102006040647A1 (de) * | 2006-08-30 | 2008-03-13 | Robert Bosch Gmbh | Handwerkzeugmaschine |
| WO2008144616A1 (en) | 2007-05-18 | 2008-11-27 | Heidi Kay | Lipid raft, caveolin protein, and caveolar function modulation compounds and associated synthetic and therapeutic methods |
| US8895610B1 (en) * | 2007-05-18 | 2014-11-25 | Heldi Kay | Platinum (IV) compounds targeting zinc finger domains |
| CA2691047A1 (en) * | 2007-06-18 | 2008-12-24 | Platco Technologies (Proprietary) Limited | Platinum (iv) complexes |
| HUE027443T2 (en) | 2007-09-10 | 2016-10-28 | Boston Biomedical Inc | A novel class of Stat3 pathway inhibitors and tumor stem cell inhibitors |
| WO2010067335A1 (en) | 2008-12-12 | 2010-06-17 | Platco Technologies (Proprietary) Limited | Platinum (iv) complexes for use in the treatment of proliferative diseases such as cancer |
| WO2011160063A2 (en) | 2010-06-18 | 2011-12-22 | Myriad Genetics, Inc. | Methods and materials for assessing loss of heterozygosity |
| ES2704303T3 (es) | 2010-08-24 | 2019-03-15 | Dana Farber Cancer Inst Inc | Procedimientos para la predicción de una respuesta contra el cáncer |
| CA2839210A1 (en) | 2011-06-17 | 2012-12-20 | Myriad Genetics, Inc. | Methods and materials for assessing allelic imbalance |
| RU2491936C2 (ru) * | 2011-07-11 | 2013-09-10 | Борис Николаевич Анисимов | Способ комплексного лечения больных паразитарными заболеваниями |
| EP3660161B1 (en) | 2011-12-21 | 2024-07-31 | Myriad Genetics, Inc. | Methods and materials for assessing loss of heterozygosity |
| EP3415915B1 (en) | 2012-02-23 | 2024-10-23 | Children's Medical Center Corporation | Methods for predicting response to parp inhibitors |
| CA2867434C (en) | 2012-06-07 | 2021-10-12 | Institut Curie | Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors |
| US10308986B2 (en) | 2013-03-14 | 2019-06-04 | Children's Medical Center Corporation | Cancer diagnosis, treatment selection and treatment |
| RU2682674C2 (ru) | 2013-03-15 | 2019-03-20 | Шерри Энн МАКФАРЛЭНД | Координационные комплексы на основе металлов в качестве фотодинамических соединений и их применение |
| AU2014248007B2 (en) | 2013-04-05 | 2020-03-26 | Myriad Genetics, Inc. | Methods and materials for assessing homologous recombination deficiency |
| WO2014198140A1 (zh) * | 2013-06-13 | 2014-12-18 | 上海医药工业研究院 | 一种铂（ⅱ）配合物、其制备方法、药物组合物及应用 |
| WO2015013565A1 (en) * | 2013-07-25 | 2015-01-29 | Nemucore Medical Innovations, Inc. | Platinum derivatives for hydrophobic formulations |
| EP4023765A1 (en) | 2013-12-09 | 2022-07-06 | Institut Curie | Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors |
| ES2800673T3 (es) | 2014-08-15 | 2021-01-04 | Myriad Genetics Inc | Métodos y materiales para evaluar una deficiencia de recombinación homóloga |
| CN108697093A (zh) | 2015-06-19 | 2018-10-23 | 新纳特产品公司 | 含卡铂的组合物及其用途 |
| AU2016279099B2 (en) | 2015-06-19 | 2021-09-23 | Syn-Nat Products Enterprise LLC | Pharmaceutical composition of carboplatin based co-crystals and use thereof |
| EP3297640A4 (en) | 2015-06-25 | 2019-01-02 | Syn-Nat Products Enterprise LLC | Pharmaceutical co-crystal composition and use thereof |
| US11299469B2 (en) | 2016-11-29 | 2022-04-12 | Sumitomo Dainippon Pharma Oncology, Inc. | Naphthofuran derivatives, preparation, and methods of use thereof |
| EP3714881A4 (en) | 2017-11-21 | 2021-09-01 | Medoncare Pharmaceutical Co., Ltd | COMBINATION PRODUCT INCLUDING DICYCLOPLATIN, ITS PREPARATION PROCESS AND ITS USE |
| CN112175014B (zh) * | 2020-10-10 | 2021-08-20 | 中国药科大学 | 一种一氧化氮供体型四价铂衍生物、制备方法及其医药用途 |
| EP4141127B1 (en) | 2021-08-30 | 2024-10-09 | Zentrum Familiärer Brust- und Eierstockkrebs Universitätsklinik Köln | Method for assessing homologous recombination deficiency in ovarian cancer cells |
| WO2024063828A1 (en) | 2022-09-21 | 2024-03-28 | Oracle International Corporation | Expert-optimal correlation: contamination factor identification for unsupervised anomaly detection |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4177263A (en) * | 1972-02-28 | 1979-12-04 | Research Corporation | Anti-animal tumor method |
| GB1432563A (en) | 1972-04-10 | 1976-04-22 | Rustenburg Platinum Mines Ltd | Platinum- co-ordination compounds |
| GR851932B (enExample) * | 1984-08-14 | 1985-12-13 | Engelhard Corp | |
| JPS6296A (ja) * | 1985-03-06 | 1987-01-06 | Sumitomo Pharmaceut Co Ltd | 脂溶性白金（２）錯体 |
| JPH01156989A (ja) * | 1987-09-25 | 1989-06-20 | Ss Pharmaceut Co Ltd | 新規白金錯体 |
| EP0328274B1 (en) * | 1988-02-02 | 1994-10-19 | Johnson Matthey, Inc., | Pt (IV) complexes |
| JP3520367B2 (ja) * | 1994-12-22 | 2004-04-19 | 独立行政法人産業技術総合研究所 | 白金ニトロアンミン系錯体の製造方法 |
| AU4842996A (en) * | 1995-02-28 | 1996-09-18 | Yoshinori Kidani | Novel platinum (iv) complexes, process for producing the same, and carcinostatic agents containing the same |
| US5922689A (en) * | 1995-09-11 | 1999-07-13 | Unitech Pharmaceuticals, Inc. | Cisplatin analogs for cancer treatment |
| US5849790A (en) * | 1995-11-17 | 1998-12-15 | The University Of South Florida | (Mono) ethylenediaminenitroplatinum (IV) complexes with ligands of oxides of nitrogen as possible anti-tumor agents |
| US6145688A (en) * | 1996-07-17 | 2000-11-14 | Smith; James C. | Closure device for containers |
| US5977393A (en) | 1997-11-21 | 1999-11-02 | California Institute Of Technology | Schiff base derivatives of ruthenium and osmium olefin metathesis catalysts |
| KR100246722B1 (ko) * | 1997-12-30 | 2000-04-01 | 박호군 | 경구용 백금 착화합물 항암제 및 그 제조방법 |
| WO2000032235A1 (de) * | 1998-11-26 | 2000-06-08 | Pentapharm Ag | Transportsystemkonjugate |
| EP1146869A2 (en) * | 1999-01-27 | 2001-10-24 | University Of South Florida | Inhibition of stat3 signal transduction for human cancer therapy |
| US6511676B1 (en) * | 1999-11-05 | 2003-01-28 | Teni Boulikas | Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| US7033597B2 (en) * | 2000-10-13 | 2006-04-25 | Université de Lausanne | Intracellular delivery of biological effectors |
| EP1345956A2 (en) | 2000-10-13 | 2003-09-24 | University of Lausanne | Intracellular delivery of biological effectors by novel transporter peptide sequences |
| US7638122B2 (en) * | 2003-03-07 | 2009-12-29 | University Of South Florida | Stat3 antagonists and their use as vaccines against cancer |
| US7754684B2 (en) | 2003-06-11 | 2010-07-13 | Access Pharmaceuticals, Inc. | Macromolecular platinum chelates |
| DE602004015811D1 (de) | 2003-08-13 | 2008-09-25 | Univ South Florida | Verfahren zur inhibierung der proliferation von tumorzellen, bei dem platinkomplexe eingesetzt werden |
| US20050288365A1 (en) | 2004-01-06 | 2005-12-29 | Heidi Kay | Platinum complexes and methods for inhibiting tumor cell proliferation |
| JP2008519859A (ja) | 2004-11-10 | 2008-06-12 | ユニバーシティー オブ サウス フロリダ | 標的化した薬物送達のための白金錯体 |
| US20100190180A1 (en) | 2005-07-06 | 2010-07-29 | Heidi Kay | Materials and Methods for Screening, Diagnosis and Prognosis of Conditions Associated With Stat Protein Expression |
-
2004
- 2004-08-13 DE DE602004015811T patent/DE602004015811D1/de not_active Expired - Lifetime
- 2004-08-13 US US10/918,769 patent/US7566798B2/en not_active Expired - Fee Related
- 2004-08-13 WO PCT/US2004/026393 patent/WO2005016946A2/en not_active Ceased
- 2004-08-13 AU AU2004264421A patent/AU2004264421B2/en not_active Ceased
- 2004-08-13 WO PCT/US2004/026392 patent/WO2005023824A2/en not_active Ceased
- 2004-08-13 US US10/918,762 patent/US7238372B2/en not_active Expired - Lifetime
- 2004-08-13 JP JP2006523413A patent/JP2007502301A/ja active Pending
- 2004-08-13 EP EP04781131A patent/EP1675864B1/en not_active Expired - Lifetime
- 2004-08-13 JP JP2006523414A patent/JP2007502777A/ja active Pending
- 2004-08-13 EP EP04809566A patent/EP1664070B1/en not_active Expired - Lifetime
- 2004-08-13 AT AT04781131T patent/ATE453653T1/de not_active IP Right Cessation
- 2004-08-13 DE DE602004024909T patent/DE602004024909D1/de not_active Expired - Lifetime
- 2004-08-13 AU AU2004270655A patent/AU2004270655B2/en not_active Ceased
- 2004-08-13 CA CA002535762A patent/CA2535762A1/en not_active Abandoned
- 2004-08-13 CA CA002535584A patent/CA2535584A1/en not_active Abandoned
- 2004-08-13 AT AT04809566T patent/ATE404574T1/de not_active IP Right Cessation
-
2007
- 2007-01-31 US US11/701,907 patent/US7763585B2/en not_active Expired - Fee Related
-
2009
- 2009-07-21 US US12/506,913 patent/US7759510B2/en not_active Expired - Fee Related
-
2010
- 2010-07-13 US US12/835,114 patent/US8247445B2/en not_active Expired - Fee Related
- 2010-07-15 US US12/837,046 patent/US8598230B2/en not_active Expired - Fee Related
-
2011
- 2011-05-23 AU AU2011202386A patent/AU2011202386A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007502301A5 (enExample) | ||
| Malaterre et al. | c-Myb is required for progenitor cell homeostasis in colonic crypts | |
| Jang et al. | H3. 3K4M destabilizes enhancer H3K4 methyltransferases MLL3/MLL4 and impairs adipose tissue development | |
| De-Santis et al. | Candidate growth genes in finfish—where should we be looking? | |
| Wang et al. | Parafibromin, a component of the human PAF complex, regulates growth factors and is required for embryonic development and survival in adult mice | |
| Dali-Youcef et al. | Adipose tissue-specific inactivation of the retinoblastoma protein protects against diabesity because of increased energy expenditure | |
| Vernia et al. | An alternative splicing program promotes adipose tissue thermogenesis | |
| Li et al. | A role for SMARCB1 in synovial sarcomagenesis reveals that SS18–SSX induces canonical BAF destruction | |
| Borengasser et al. | Maternal obesity enhances white adipose tissue differentiation and alters genome-scale DNA methylation in male rat offspring | |
| Yoshida et al. | The role of Bcl6 in mature cardiac myocytes | |
| Ou et al. | Targeted demethylation at the CDKN1C/p57 locus induces human β cell replication | |
| Safer et al. | A role for thyroid hormone in wound healing through keratin gene expression | |
| JP2019106999A (ja) | 多能性幹細胞の有用性および安全性の特徴決定を行うための機能的ゲノミクスアッセイ | |
| Warnock et al. | Effect of castration technique on beef calf performance, feed efficiency, and inflammatory response | |
| Arjona et al. | Identification and functional characterization of zebrafish solute carrier Slc16a2 (Mct8) as a thyroid hormone membrane transporter | |
| Meel et al. | MEK/MELK inhibition and blood–brain barrier deficiencies in atypical teratoid/rhabdoid tumors | |
| Engström et al. | Transcriptional regulation and biological significance of the insulin like growth factor II gene | |
| Suzuki et al. | Identical sets of methylated and nonmethylated genes in Ciona intestinalis sperm and muscle cells | |
| Byamba et al. | Skin‐penetrating methotrexate alleviates imiquimod‐induced psoriasiform dermatitis via decreasing IL‐17‐producing gamma delta T cells | |
| Fiol et al. | Regulation of osmotic stress transcription factor 1 (Ostf1) in tilapia (Oreochromis mossambicus) gill epithelium during salinity stress | |
| Porter et al. | Fetal and neonatal hematopoietic progenitors are functionally and transcriptionally resistant to Flt3-ITD mutations | |
| Tessier et al. | Exploration of nuclear body-enhanced sumoylation reveals that PML represses 2-cell features of embryonic stem cells | |
| Simmet et al. | Manipulating the epigenome in nuclear transfer cloning: Where, when and how | |
| Volland et al. | Control of p21Cip by BRCA1-associated protein is critical for cardiomyocyte cell cycle progression and survival | |
| Yoshida et al. | Requirement of CDC45 for postimplantation mouse development |